Table 5: Comparison of samples from the nPDR group and the MH group (median, minimum–maximum; Mann Whitney test).

VitreousBlood
nPDR ( )MH ( )P valuenPDR ( )MH ( )P value

CD45 (number)401.0 (181.0–1644.0)132.0 (80.0–429.0)0.005107079.5 (100911.0–168812.0)109862.5 (100618.0–127659.0)0.64
Ly (%)3.3 (0.4–55.5)1.0 (0–2.6)0.04430.2 (10.4–82.1)23.0 (14.3–63.9)0.512
CD14all (%)64.1 (34.0–79.3)52.75 (17.9–83.0)0.2236.0 (2.2–12.0)8.0 (5.0–21.0)0.144
CD19 (%)0 (0-0)0 (0-0)0.488.4 (3.0–83.0)8.45 (4.9–19.4)0.925
CD3 (%)57.5 (0–100.0)0 (0-0)0.02559.9 (12.6–95.6)61.1 (36.6–67.0)0.453
CD3/CD1984.0 (47.7–100.0)7.5 (3.1–27.0)4.6 (2.8–13.3)0.454
CD4 (%)64.0 (0–100.0)0 (0-0)0.02561.3 (24.7–78.4)58.8 (32.0–75.3)0.851
CD8 (%)0 (0–26.0)0 (0-0)0.07532.3 (16.9–68.2)33.4 (21.4–59.4)1.0
CD4/CD83.9 (2.2–100.0)2.05 (0.4–8.2)1.8 (1.3–3.5)0.963

Legend: nPDR: PDR patients with blood non-contaminated vitreous; MH: patients with macular hole; CD45+: leukocytes; Ly: lymphocytes; CD14+: macrophages; CD19+: B lymphocytes; CD3+: T lymphocytes; CD4+: T helper lymphocytes; CD8+: T cytotoxic lymphocytes.